T. Rowe Price Associates’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $555K | Buy |
|
|||||
|
2025
Q2 | $668K | Buy |
|
|||||
|
2025
Q1 | $295K | Buy |
|
|||||
|
2024
Q4 | $263K | Buy |
|
|||||
|
2024
Q3 | $168K | Hold |
|
|||||
|
2024
Q2 | $130K | Buy |
|
|||||
|
2024
Q1 | $110K | Hold |
|
|||||
|
2023
Q4 | $75K | Hold |
|
|||||
|
2023
Q3 | $69K | Sell |
|
|||||
|
2023
Q2 | $76K | Sell |
|
|||||
|
2023
Q1 | $60K | Sell |
|
|||||
|
2022
Q4 | $96K | Hold |
|
|||||
|
2022
Q3 | $54K | Buy |
|
|||||
|
2022
Q2 | $17K | Sell |
|
|||||
|
2022
Q1 | $45K | Buy |
|
|||||
|
2021
Q4 | $100K | Sell |
|
|||||
|
2021
Q3 | $137K | Buy |
|
|||||
|
2021
Q2 | $174K | Buy |
|
|||||
|
2021
Q1 | $144K | Sell |
|
|||||
|
2020
Q4 | $120K | Buy |
|
|||||
|
2020
Q3 | $92K | Buy |
|
|||||
|
2020
Q2 | $375K | Buy |
|
|||||
|
2020
Q1 | $200K | Buy |
|
|||||
|
2019
Q4 | $162K | Buy |
|
|||||
|
2019
Q3 | $83K | Buy |
|
|||||
|
2019
Q2 | $99K | Buy |
|
|||||
|
2019
Q1 | $160K | Buy |
|
|||||
|
2018
Q4 | $107K | Sell |
|
|||||
|
2018
Q3 | $199K | Buy |
|
|||||
|
2018
Q2 | $222K | Buy |
|
|||||
|
2018
Q1 | $211K | Buy |
|